Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2016 2
2017 5
2018 2
2019 2
2020 6
2021 8
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Endothelial connexin-integrin crosstalk in vascular inflammation.
Okamoto T, Park EJ, Kawamoto E, Usuda H, Wada K, Taguchi A, Shimaoka M. Okamoto T, et al. Among authors: usuda h. Biochim Biophys Acta Mol Basis Dis. 2021 Sep 1;1867(9):166168. doi: 10.1016/j.bbadis.2021.166168. Epub 2021 May 13. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33991620 Free article. Review.
Endotoxins and Non-Alcoholic Fatty Liver Disease.
Kessoku T, Kobayashi T, Imajo K, Tanaka K, Yamamoto A, Takahashi K, Kasai Y, Ozaki A, Iwaki M, Nogami A, Honda Y, Ogawa Y, Kato S, Higurashi T, Hosono K, Yoneda M, Okamoto T, Usuda H, Wada K, Kobayashi N, Saito S, Nakajima A. Kessoku T, et al. Among authors: usuda h. Front Endocrinol (Lausanne). 2021 Oct 29;12:770986. doi: 10.3389/fendo.2021.770986. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34777261 Free PMC article. Review.
The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target.
Kessoku T, Kobayashi T, Tanaka K, Yamamoto A, Takahashi K, Iwaki M, Ozaki A, Kasai Y, Nogami A, Honda Y, Ogawa Y, Kato S, Imajo K, Higurashi T, Hosono K, Yoneda M, Usuda H, Wada K, Saito S, Nakajima A. Kessoku T, et al. Among authors: usuda h. Int J Mol Sci. 2021 Jul 29;22(15):8161. doi: 10.3390/ijms22158161. Int J Mol Sci. 2021. PMID: 34360923 Free PMC article. Review.
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Usuda H, Wada K, Kobayashi N, Saito S, Nakajima A, Yoneda M. Iwaki M, et al. Among authors: usuda h. Hepatol Commun. 2023 Oct 31;7(11):e0285. doi: 10.1097/HC9.0000000000000285. eCollection 2023 Nov 1. Hepatol Commun. 2023. PMID: 37902528 Free PMC article.
A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.
Sato S, Kamata Y, Kessoku T, Shimizu T, Kobayashi T, Kurihashi T, Takashiba S, Hatanaka K, Hamada N, Kodama T, Higurashi T, Taguri M, Yoneda M, Usuda H, Wada K, Nakajima A, Morozumi T, Minabe M. Sato S, et al. Among authors: usuda h. Sci Rep. 2022 Aug 10;12(1):13621. doi: 10.1038/s41598-022-17917-2. Sci Rep. 2022. PMID: 35948584 Free PMC article.
Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial.
Kamata Y, Kessoku T, Shimizu T, Sato S, Kobayashi T, Kurihashi T, Morozumi T, Iwasaki T, Takashiba S, Hatanaka K, Hamada N, Kodama T, Higurashi T, Taguri M, Yoneda M, Usuda H, Wada K, Nakajima A, Minabe M. Kamata Y, et al. Among authors: usuda h. Clin Transl Gastroenterol. 2022 Nov 1;13(11):e00520. doi: 10.14309/ctg.0000000000000520. Clin Transl Gastroenterol. 2022. PMID: 36000999 Free PMC article. Clinical Trial.
32 results